Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR
Sponsor: Wake Forest University Health Sciences
Summary
The purpose of this prospective, randomized, double-blinded study is to further evaluate the safety and efficacy of varying doses of intravenous magnesium in the treatment of AFF RVR.
Official title: Atrial Tachycardia Reduction With Intravenous Use of Magnesium (ATRIUM) Study: Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
153
Start Date
2024-10-07
Completion Date
2026-12
Last Updated
2025-10-28
Healthy Volunteers
No
Interventions
Magnesium Sulfate 2 G
Magnesium Sulfate 2g for the treatment of atrial fibrillation or atrial flutter with rapid ventricular response (AFF RVR)
Magnesium Sulfate 4 G
Magnesium Sulfate 4g for the treatment of atrial fibrillation or atrial flutter with rapid ventricular response (AFF RVR)
Saline
The control group will receive a bolus of normal saline of the same volume and infused over 15 minutes.
Locations (1)
Advocate Christ Medical Center Emergency Department (ACMC ED)
Oak Lawn, Illinois, United States